Effects of drug-polymer dispersions on solubility and in vitro diffusion of artemisinin across a polydimethylsiloxane membrane

Chinese Science Bulletin

Volumn 57, Issue 14, 2012, Pages 1685-1692

  Shahzad, Yasser ^a,b   Shah, Syed Nisar Hussain ^a   Ansari, Muhammad Tayyab ^a   Riaz, Romana ^a   Safdar, Aasma ^a   Hussain, Talib ^a,b   Malik, Madeeha ^c  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^c HAMDARD UNIVERSITY   (Pakistan)

Author keywords

artemisinin; flux; permeability coefficient; polyvinylpyrrolidone; silicone membrane; solid dispersions; solubility

Indexed keywords

EID: 84860003044     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-012-5094-2     Document Type: Article

References (38)

1. Svensson U S H, Sandström R, Carlborg Ö, et al. High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metab Dispos, 1999, 27: 227-232.
2. Thaithong S, Beale G H. Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine [qinghaosu] and artemether. Bull World Health Organ, 1985, 63: 617-619.
3. Klayman D L. Qinghaosu [artemisinin]: An antimalarial drug from China. Science, 1985, 228: 1049-1055.
4. Titulaer H, Zuidema J, Kager P, et al. The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharma Pharmacol, 1990, 42: 810-813.
5. Wong J, Yuen K. Improved oral bioavailability of artemisinin through inclusion complexation with (beta)-and (gamma)-cyclodextrins. Int J Pharm, 2001, 227: 177-185.
6. Sahoo N G, Kakran M, Li L, et al. Dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier. Mat Sci Eng C, 2011, 31: 391-399.
7. Stoughton R B. Percutaneous absorption. South Med J, 1962, 55: 1134-1138.
8. Kim J H, Choi H K. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int J Pharm, 2002, 236: 81-85.
9. Barry B W. Skin transport. In: Dermatological Formulations Percutaneous Absorption. New York: Marcel Dekker, 1983. 95-126.
10. Iwasa A, Irimoto K, Kasai S, et al. Effect of nonionic surfactants on percutaneous absorption of diclofenac sodium. Yakuzaigaku, 1991, 51: 16-21.
11. Javadzadeh Y, Shokri J, Hallaj-Nezhadi S, et al. Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol, 2009: 1-7.
12. Pathan I B, Setty C M. Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res, 2009, 8: 173-179.
13. Karavas E, Ktistis G, Xenakis A, et al. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J Pharm Biopharm, 2006, 63: 103-114.
14. Ruan L P, Yu B Y, Fu G M, et al. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal, 2005, 38: 457-464.
15. Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm, 1996, 143: 59-66.
16. van Nijlen T, Brennan K, van den Mooter G, et al. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. Int J Pharm, 2003, 254: 173-181.
17. Akbuga J, Gürsoy A, Kendi E. The preparation and stability of fast release furosemide-PVP solid dispersion. Drug Dev Ind Pharm, 1988, 14: 1439-1464.
18. Margarit M V, Marín M T, Contreras M D. Solubility of solid dispersions of pizotifen malate and povidone. Drug Dev Ind Pharm, 2001, 27: 517-522.
19. El-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm, 2006, 32: 141-150.
20. Zhao S S, Zeng M Y. Spektrometrische Hochdruck-Flüssigkeits-Chromatographische [HPLC] Untersuchungen zur Analytik von Qinghaosu. Planta Med, 1985, 51: 233-237.
21. Ansari M T, Iqbal I, Sunderland V B. Dihydroartemisinin-cyclodextrin complexation: Solubility and stability. Arch Pharmacal Res, 2009, 32: 155-165.
22. Franz T J. Percutaneous absorption: On the relevance of in vitro data. J Invest Dermatol, 1975, 64: 190-195.
23. Avery M A, Bonk J D, Chong W K M, et al. Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: Synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins. J Med Chem, 1995, 38: 5038-5044.
24. Sammour O A, Hammad M A, Megrab N A, et al. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech, 2006, 7: 167-175.
25. Chiou W L, Riegelman S. Pharmaceutical applications of solid dispersions. J Pharm Sci, 1971, 60: 1281-1302.
26. Abdelkader H, Abdallah O Y, Salem H S. Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide. AAPS PharmSciTech, 2007, 8: 110-117.
27. Shah J, Vasanti S, Anroop B, et al. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: Preparation and in vitro evaluation. J Incl Phen Macro, 2009, 63: 69-75.
28. Liu C, Desai K G H. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev Ind Pharm, 2005, 31: 1-10.
29. Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion [kneading] technique. AAPS PharmSciTech, 2006, 7: 87-92.
30. Betageri G V, Makarla K R. Enhancemnet of dissolution of glyburide by solid dispersion and lyophilisation techniques. Int J Pharm, 1995, 126: 155-160.
31. Barry B W. Properties that influence. In: Dermatological Formulations Percutaneous Absorption. New York: Marcel Decker, 1983. 127-233.
32. Chow D. Concentration dependent enhancement of 1-dodecylazacy-cloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide. J Pharm Sci, 1984, 73: 1794-1799.
33. Huang Y B, Wu P C, Ko H M, et al. Cardamom oil as a skin permeation enhancer for indomethacin, piroxicam and diclofenac. Int J Pharm, 1995, 126: 111-117.
34. Dias M, Hadgraft J, Lane M E. Influence of membrane-solvent-solute interactions on solute permeation in model membranes. Int J Pharm, 2007, 336: 108-114.
35. Watkinson A C, Joubin H, Green D M, et al. The influence of vehicle on permeation from saturated solutions. Int J Pharm, 1995, 121: 27-36.
36. Raghavan S, Kiepfer B, Davis A, et al. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm, 2001, 221: 95-105.
37. Kim J H, Lee C H, Choi H K. Transdermal delivery of physostigmine: Effects of enhancers and pressure-sensitive adhesives. Drug Dev Ind Pharm, 2002, 28: 833-839.
38. Zhang J, Liu Z, Du H, et al. A novel hydrophilic adhesive matrix with self-enhancement for drug percutaneous permeation through rat skin. Pharm Res, 2009, 26: 1398-1406.